Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia
Boston Children's Hospital · NCT04712812
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Up to age 30 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 700
- US sites recruiting
- 1
- Study start
- April 27, 2020
- Record last updated
- March 18, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia (HSP) is focused on gathering longitudinal clinical data as well as biological samples (skin and/or blood and/or saliva) from male and female patients, under the age of 30, who exhibited early onset symptoms of HSP with (1) a clinical diagnosis of hereditary spastic paraplegia and (2) the presence of variants in HSP related genes and/or be a relative of a person with such a diagnosis. Currently, the treatment for this disorder is generally symptomatic and available therapies improve quality of life, but are grossly inefficient in slowing the disease progression. Access to the registry information will be limited to the study staff who are responsible for recruitment and maintenance of the registry. We hope that recruitment into the registry for studies will advance knowledge of the causes, clinical course, diagnosis, and treatment of these conditions.
Conditions: Hereditary Spastic Paraplegia; SPG47; SPG50; SPG51; SPG52; AP4-related Hereditary Spastic Paraplegia; Early Onset Hereditary Spastic Paraplegia; SPG4; SPG3A; SPG15; SPG11
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Onset of hereditary spastic paraplegia symptoms before the age of 18 years
- Under the age of 30 years old
- Must have a genetically confirmed variant in HSP-related genes and a relative of an individual with a confirmed diagnosis (if applicable).
Exclusion Criteria
- Not having such a diagnosis and/or not being related to such individual
Recruiting US locations
Boston Children's Hospital
Boston, MA 02115
Site contact: Darius Ebrahimi-Fakhari, MD, PhD · 617-355-6388 · Darius.Ebrahimi-Fakhari@childrens.harvard.edu
Study contacts (from the official record)
- Darius Ebrahimi-Fakhari, MD, PhD · 617-355-6388 · hsp.research@childrens.harvard.edu
- Nicole Battaglia, BS · hsp.research@childrens.harvard.edu
Similar studies in Massachusetts
All healthy volunteers studies in Massachusetts →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
Haya Therapeutics, Inc.
- Location
- Boston, MA + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Boston, MA + 49 other US sites
- Eligibility basics
- Ages 60+